Oxyresveratrol ameliorates nonalcoholic fatty liver disease by regulating hepatic lipogenesis and fatty acid oxidation through liver kinase B1 and AMP-activated protein kinase
Ju‐Hee Lee(Dongguk University), Young Woo Kim(University of Seoul), Kwang‐Il Park(Gyeongsang National University), Eun Jeong Jang(Dong-A University), Chang-Eop Kim(Gachon University), Sae‐Kwang Ku(Daegu Haany University), Sang Chan Kim(Daegu Haany University), Su Youn Baek(Daegu Haany University), Kyu Min Kim(Chosun University), Sung Hwan Ki(Chosun University)
Cited by 45
Related Papers
Long-range interaction and correlation between <i>MYC</i> enhancer and oncogenic long noncoding RNA <i>CARLo-5</i>
|Proceedings of the National Academy of Sciences|2014|186
Mechanisms of Resistance to Histone Deacetylase Inhibitors
|Advances in cancer research|2012|101
Class II histone deacetylases play pivotal roles in heat shock protein 90-mediated proteasomal degradation of vascular endothelial growth factor receptors
|Biochemical and Biophysical Research Communications|2008|100
Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells
|Molecular Cancer Therapeutics|2006|100